CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 56 filers reported holding CABALETTA BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,539 | +92.7% | 3,452 | +63.4% | 0.00% | +100.0% |
| Q2 2023 | $27,266 | +127.2% | 2,112 | +87.7% | 0.00% | – |
| Q1 2021 | $12,000 | -14.3% | 1,125 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $14,000 | +16.7% | 1,125 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $12,000 | +100.0% | 1,125 | +100.9% | 0.00% | – |
| Q2 2020 | $6,000 | +50.0% | 560 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -50.0% | 560 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | – | 560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |